Atopic dermatitis (eczema): open trials in Germany

30 open trials have a site in Germany. Registry data; only the trial team decides who can take part.

NCT06807281
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Technische Universitaet Dresden, Dresden · Universitaet Muenster, Muenster
Registry updated 2026-11-05
NCT07216027
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Trial Treatment · Phase 2 · Pfizer
Derma-Study-Center Friedrichshafen GmbH, Friedrichshafen · Universitaetsklinikum Schleswig-Holstein AöR, Kiel · Universitaetsklinikum Schleswig-Holstein AöR, Luebeck · Universitaetsklinikum Muenster AöR, Muenster
Registry updated 2026-11-05
NCT07918586
Localized Aeroallergen Exposure in Atopic Dermatitis
Trial Treatment · Fraunhofer-Institute of Toxicology and Experimental Medicine
Hannover Medical School, Department of Dermatology and Allergy, Hanover · Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Clinical Airway Research, Hanover
Registry updated 2026-11-05
NCT07003425
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Trial Treatment · Phase 2 · Apogee Therapeutics, Inc.
Augsburg · Bad Bentheim · Berlin · Blankenfelde-Mahlow · Darmstadt · Dresden · Frankfurt am Main · Freiburg im Breisgau · Hamburg · Heidelberg · Kiel · München · Münster · Tübingen
Registry updated 2026-11-03
NCT07904546
ADBest TREAT Registry
Research · Universitätsklinikum Hamburg-Eppendorf
Institute for Health Services Research in Dermatology and Nursing, IVDP; University Medical Center Hamburg-Eppendorf,UKE, Hamburg
Registry updated 2026-10-29
2026-525673-39-00
A Phase 2b Study of the Effects of Camoteskimab in Adults with Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Apollo Therapeutics Limited
Thermalsole und Schwefelbad Bentheim GmbH, Bad Bentheim · Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR, Dresden · Universitaetsklinikum Frankfurt AöR, Frankfurt Am Main · Dermatologikum Hamburg Gmbh, Hamburg · University Of Luebeck, Luebeck · Universitaet Muenster, Muenster
Registry updated 2026-10-28
2024-511390-30-00
Clinical study to compare two cutaneous creams with the active substance methylprednisolone aceponate 0.1% and one cutaneous cream without active substance for patients with atopic dermatitis
Trial Treatment · Phase 3 · Dermapharm AG
Praxis Dr. Julia Reichle, Berlin · MVZ Dermatologisches Zentrum Bonn GmbH, Bonn · Hautarztpraxis Dr. Pfennig, Crimmitschau · Praxis Dr. med. Abdou Zarzour, Halle · Hautarztpraxis Dr. Offers und Dr. Adamini, Ibbenbüren · Hautarztpraxis, Kiel · Haut-und Lasercentrum Potsdam - Dr. med. Tanja Fischer, Potsdam · Haut- und Laserzentrum Hunsrück, Gesundheitszentrum Simmern, Dermatologisches Studienzentrum, Simmern · Hautarztpraxis Kock, Vechta
Registry updated 2026-10-26
NCT05735483
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 3 · Eli Lilly and Company
Thermalsole und Schwefelbad Bentheim GmbH, Bad Bentheim · Rosenpark Research Gmbh, Darmstadt · Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR, Dresden · Universitaetsklinikum Frankfurt AöR, Frankfurt Am Main · Universitaetsklinikum Muenster AöR, Münster
Registry updated 2026-10-26
NCT05099315
Microbiome in Atopic Dermatitis Under Systemic Therapy
Research · Charite University, Berlin, Germany
Dpt of Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Berlin
Registry updated 2026-10-22
NCT07873801
A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
Trial Treatment · Phase 3 · Almirall, S.A.
Universitaetsklinikum Augsburg, Augsburg · Thermalsole und Schwefelbad Bentheim GmbH, Bad Bentheim · Charite Universitaetsmedizin Berlin KöR, Berlin · St. Josef Hospital, Bochum · Universitaetsklinikum Koeln AöR, Cologne · Technische Universitaet Dresden, Dresden · Universitaetsklinikum Duesseldorf AöR, Duesseldorf · Universitaetsklinikum Erlangen AöR, Erlangen · Goethe University Frankfurt, Frankfurt Am Main · Medical Center- University of Freiburg, Freiburg im Breisgau · Universitaetsmedizin Goettingen, Goettingen · University Medical Center Hamburg-Eppendorf, Hamburg · Medizinische Hochschule Hannover, Hanover · Universitaetsklinikum Heidelberg AöR, Heidelberg · Universitaetsklinikum Schleswig-Holstein AöR, Kiel · Universitaetsklinikum Schleswig-Holstein AöR, Luebeck · Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Mainz · Universitaet Muenster, Muenster · Klinikum der Technischen Universitaet Muenchen (TUM Klinikum), Munich · LMU Klinikum Muenchen AöR, Munich · Universitaetsklinikum Regensburg AöR, Regensburg · Rostock University Medical Center, Rostock · Universitaetsklinikum Tuebingen AöR, Tuebingen
Registry updated 2026-10-14
2026-526184-38-00
A study to Evaluate the Efficacy and Safety of ENV-294 in Adult Participants with Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Enveda Therapeutics Inc.
Charite Universitaetsmedizin Berlin KöR, Berlin · Goethe University Frankfurt, Frankfurt Am Main · University Medical Center Hamburg-Eppendorf, Hamburg · Eurofins bioskin GmbH, Hamburg · Universitaetsklinikum Schleswig-Holstein AöR, Kiel · Universitaetsklinikum Schleswig-Holstein AöR, Luebeck · Universitaet Muenster, Muenster
Registry updated 2026-09-28
NCT06947993
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Thermalsole und Schwefelbad Bentheim GmbH, Bad Bentheim · Praxis fuer Dermatologie und Venerologie, Dresden · Goethe University Frankfurt, Frankfurt Am Main · Universitaetsmedizin Goettingen, Goettingen · University Medical Center Hamburg-Eppendorf, Hamburg · Universitaetsklinikum Heidelberg AöR, Heidelberg · Universitaetsklinikum Magdeburg AöR, Magdeburg · BAG Dres. Med. Quist PartG, Mainz Bretzenheim · Universitaet Muenster, Muenster · Klinikum Oldenburg Aor, Oldenburg · Klinische Forschung Osnabrueck, Osnabrueck
Registry updated 2026-09-28
NCT06807268
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Technische Universitaet Dresden, Dresden · Universitaet Muenster, Muenster
Registry updated 2026-09-25
2025-521658-40-00
A first-in-human, dose finding study to evaluate the safety, tolerability and pharmacokinetics of EGL-003 in healthy volunteers followed by adults with autoimmune disease.
Trial Treatment · Phase 1 · Egle Therapeutics
Thermalsole und Schwefelbad Bentheim GmbH, Bad Bentheim · Charite Universitaetsmedizin Berlin KöR, Berlin · Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR, Dresden · Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Mainz
Registry updated 2026-08-28
NCT05928169
Determinants of Chronic Inflammatory Skin Disease Trajectories
Research · University Hospital Schleswig-Holstein
Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel
Registry updated 2026-08-28
NCT07599813
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Apollo Therapeutics Ltd
Fachklinik Bad Bentheim, Bad Bentheim · University Hospital Dresden, Dresden · Universitatsklinikum Frankfurt Klinik fur Dermatologie, Venerologie und Allergologie, Frankfurt · Dermatologikum Hamburg Gmbh, Hamburg · University of Luebeck, Lübeck · University Hospital of Muenster, Münster · Hautarztpraxis Dr. Hoffmann, Witten
Registry updated 2026-08-28
2024-519795-11-00
A Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis
Trial Treatment · Phase 2 · Apogee Therapeutics Inc.
Universitaetsklinikum Augsburg, Augsburg · Thermalsole und Schwefelbad Bentheim GmbH, Bad Bentheim · Charite Universitaetsmedizin Berlin KöR, Berlin · Fachaerztliche Gemeinschaftspraxis fuer Dermatologie Und Venerologie Allergologie Umweltmedizin Lasermedizin GbR, Blankenfelde-Mahlow · Rosenpark Research Gmbh, Darmstadt · Technische Universitaet Dresden, Dresden · Universitaetsklinikum Frankfurt AöR, Frankfurt Am Main · Medical Center- University of Freiburg, Freiburg im Breisgau · Dermatologikum Hamburg Gmbh, Hamburg · Universitaetsklinikum Heidelberg AöR, Heidelberg · Universitaetsklinikum Schleswig-Holstein AöR, Kiel · Universitaetsklinikum Schleswig-Holstein AöR, Luebeck · Universitaet Muenster, Muenster · LMU Klinikum Muenchen AöR, Munich · Universitaetsklinikum Tuebingen AöR, Tuebingen
Registry updated 2026-08-18
NCT07542483
A Study of Lebrikizumab in Adults With Nummular Eczema
Trial Treatment · Phase 3 · Almirall, S.A.
Freiburg im Breisgau
Registry updated 2026-08-17
NCT07037901
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Inmagene LLC
Universitaetsklinikum Augsburg, Augsburg · Thermalsole und Schwefelbad Bentheim GmbH, Bad Bentheim · Charite Universitaetsmedizin Berlin KöR, Berlin · Rosenpark Research Gmbh, Darmstadt · Technische Universitaet Dresden, Dresden · Universitaetsklinikum Frankfurt AöR, Frankfurt Am Main · Dermatologikum Hamburg Gmbh, Hamburg · Universitaetsklinikum Schleswig-Holstein AöR, Luebeck · Universitaet Muenster, Muenster · Universitaetsklinikum Tuebingen AöR, Tuebingen
Registry updated 2026-08-12
NCT06943469
Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function
Trial Treatment · Société des Produits Nestlé (SPN)
Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK), Berlin · Evangelisches Krankenhaus Düsseldorf - Frauenklinik, Düsseldorf · Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Frankfurt, Frankfurt · Evangelisches Waldkrankenhaus Spandau, Spandau · Marien Hospital Wesel GmbH, Wesel
Registry updated 2026-07-30
NCT06311682
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Trial Treatment · Phase 3 · LEO Pharma
Elbe Kliniken Stade-Buxtehude Elbe Klinikum Buxtehude gGmbH, Buxtehude · Technische Universitaet Dresden, Dresden · Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Mainz · Klinische Forschung Osnabrueck, Osnabrueck · MVZ Corius Potsdam GmbH, Potsdam · Universitaetsklinikum Tuebingen AöR, Tuebingen · Helios Universitaetsklinikum Wuppertal, Wuppertal
Registry updated 2026-07-07
NCT07603193
Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream
Research · LEO Pharma
LEO Pharma, Neu-Isenburg
Registry updated 2026-05-22
NCT07558668
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Trial Treatment · Phase 1 · Sitryx Therapeutics Ltd
Berlin · Frankfurt · Freiburg im Breisgau
Registry updated 2026-04-30
NCT06988605
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Research · Galderma R&D
Ahaus · Augsburg · Augsburg · Berlin · Berlin · Berlin · Bernau bei Berlin · Bielefeld · Buxtehude · Erlangen · Gladbeck · Großenhain · Haslach im Kinzigtal · Hersbruck · Karlsruhe · Koblenz · Langenau · Lübeck · Mainz · Oberursel · Oranienburg · Pforzheim · Quedlinburg · Regensburg · Remscheid
Registry updated 2026-03-13
NCT07441395
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Trial Treatment · Phase 2 · Corvus Pharmaceuticals, Inc.
Universitaetsklinikum Augsburg, Augsburg · Charite Universitaetsmedizin Berlin KöR, Berlin · Technische Universitaet Dresden, Dresden · Goethe University Frankfurt, Frankfurt Am Main · Universitaetsklinikum Schleswig-Holstein AöR, Luebeck · Universitaet Muenster, Muenster
Registry updated 2026-03-05

All Atopic dermatitis (eczema) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error